bpc 157 kaina BPC-157 — Peptidas Sąnariams ir Atsigavimui BPC-157 | Research Peptide
Description
Systemic tissue-repair dosing runs 1 mg to 2.5 mg subcutaneously, three times per week
That is a very different evidence class than an FDA-approved drug carrying settled phase-three data, and the difference is clinically meaningful rather than a technicality
From Empower injection to Empower ODT Switching from injection to the oral disintegrating tablet is more complex because bioavailability likely differs between the two routes
(Reddit Logs & Evidence)
